Ke Ning Bio is an innovative ophthalmic pharmaceutical manufacturer dedicated to developing ophthalmic drugs.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 1, 2022 | Seed | ¥100M | 1 |
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Seed |